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Background:  Obesity has been associated with subclinical LV contractile dysfunction, even in the presence of a normal EF. The extent to which 
subclinical LV dysfunction is reversible in obese versus non-obese individuals is unknown.
Methods:  We studied a subset of 166 patients (51% women; 51% obese) from the Exforge Intensive Control of Hypertension to Evaluate Efficacy 
in Diastolic Dysfunction (EXCEED) trial who underwent 24 weeks of intensive vs. standard anti-hypertensive therapy with valsartan + amlodipine 
(titrated to goal SBP <135 vs <140 mmHg) and had baseline and follow-up echocardiography. We examined the relation of BMI with reversibility of 
contractile dysfunction, as reflected by global longitudinal systolic strain.
Results:  Obese compared to non-obese patients had similar systolic contractile function at baseline (-17.2±3.6% vs -17.3 ±4.4; P=0.77) but 
worse contractile function at follow up (-18.1±3.1% vs -19.4 ±3.8; P=0.02). Percent improvement in contractile function was less in patients with 
greater BMI (Figure). In multivariable analyses, greater BMI was associated with significantly less improvement in longitudinal strain (`=0.596; 
P=0.01) after adjusting for age, sex, treatment arm, change in SBP, and baseline measures of SBP, DBP, EF, LVM, E’, and longitudinal strain.
Conclusion:  In the setting of hypertensive heart disease with normal EF, patients with increased BMI experience less improvement in contractile 
function following treatment with antihypertensive therapy.
 
